This increase does not indicate cardiac damage but rather represents a pharmacological effect that should be distinguished from pathological tachycardia
If tirzepatide gets approved for additional indications like NASH, sleep apnea, CKD, heart failure, pre-diabetes, etc., it could significantly increase the market opportunity for Eli Lilly
De esta forma, y a pesar de que algunas personas, incluso celebridades, estn utilizando este frmaco para bajar de peso, lo cierto es que algunos estudios clnicos ya hablan de un efecto rebote
Who Should Consider GLP-1s
And we also use your suggestions to plan our episodes
A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)